231
TITLE: Ovarian preservation in stage I low-grade endometrial stromal sarcomas
AUTHORS: Andrew J Li; Robert L Giuntoli; Richard Drake; Sharon Young Byun; Francisco Rojas; Denise Barbuto; Nancy Klipfel; Pamela Edmonds; David Scott Miller ; Beth Y Karlan;
PUBLISHED: 2005, SOURCE: Obstetrics and Gynecology, VOLUME: 106, ISSUE: 6
INDEXED IN: Scopus CrossRef: 80
232
TITLE: Phase II clinical trial of capecitabine in ovarian carcinoma recurrent 6-12 months after completion of primary chemotherapy, with exploratory TS, DPD, and TP correlates: A Gynecologic Oncology Group study  Full Text
AUTHORS: Agustin A Garcia; John A Blessing; Heinz Josef Lenz; Kathleen M Darcy; Robert S Mannel; David Scott Miller ; Nader Husseinzadeh;
PUBLISHED: 2005, SOURCE: Gynecologic Oncology, VOLUME: 96, ISSUE: 3
INDEXED IN: Scopus CrossRef: 11
233
TITLE: Phase II evaluation of 9-aminocamptothecin (9-AC, NSC #603071) in platinum-resistant ovarian and primary peritoneal carcinoma: A Gynecologic Oncology Group Study  Full Text
AUTHORS: David Scott Miller ; John A Blessing; Steven Waggoner; Jeanne Schilder; Joel Sorosky; Jeffrey Bloss; Russell Schilder;
PUBLISHED: 2005, SOURCE: Gynecologic Oncology, VOLUME: 96, ISSUE: 1
INDEXED IN: Scopus CrossRef: 18
234
TITLE: Phase II evaluation of topotecan in carcinosarcoma of the uterus: A Gynecologic Oncology Group study  Full Text
AUTHORS: David Scott Miller ; John A Blessing; Jeanne Schilder; Adnan Munkarah; Yi Chun Lee;
PUBLISHED: 2005, SOURCE: Gynecologic Oncology, VOLUME: 98, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
235
TITLE: Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A Gynecologic Oncology Group study
AUTHORS: Harry J Long; Brian N Bundy; Edward C Grendys; Jo Ann Benda; Scott S McMeekin; Joel Sorosky; David Scott Miller ; Lynne A Eaton; James V Fiorica; Denise Mackey;
PUBLISHED: 2005, SOURCE: Journal of Clinical Oncology, VOLUME: 23, ISSUE: 21
INDEXED IN: Scopus CrossRef: 434
236
TITLE: Aberrant p16 methylation is a biomarker for tobacco exposure in cervical squamous cell carcinogenesis  Full Text
AUTHORS: Jayanthi S Lea; Robert Coleman; Aleena Kurien; John O Schorge; David Scott Miller ; John D Minna; Carolyn Y Muller;
PUBLISHED: 2004, SOURCE: American Journal of Obstetrics and Gynecology, VOLUME: 190, ISSUE: 3
INDEXED IN: Scopus CrossRef: 35
237
TITLE: Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study  Full Text
AUTHORS: Franco M Muggia; John A Blessing; Michael Method; David Scott Miller ; Gary A Johnson; Roger B Lee; Andrew Menzin;
PUBLISHED: 2004, SOURCE: Gynecologic Oncology, VOLUME: 92, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
238
TITLE: Oral dexamethasone attenuates Doxil®-induced palmar-plantar erythrodysesthesias in patients with recurrent gynecologic malignancies  Full Text
AUTHORS: Richard D Drake; Michael M Lin; Melanie King; Diana Farrar; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2004, SOURCE: Gynecologic Oncology, VOLUME: 94, ISSUE: 2
INDEXED IN: Scopus CrossRef: 44
239
TITLE: Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer
AUTHORS: John O Schorge; Richard D Drake; Hang Lee; Steven J Skates; Ramababu Rajanbabu; David Scott Miller ; Jae Hoon Kim; Daniel W Cramer; Ross S Berkowitz; Samuel C Mok;
PUBLISHED: 2004, SOURCE: Clinical Cancer Research, VOLUME: 10, ISSUE: 10
INDEXED IN: Scopus CrossRef: 64
240
TITLE: Other primary malignancies in patients with uterine corpus malignancy  Full Text
AUTHORS: Jacquelyn B Delin; David Scott Miller ; Robert L Coleman;
PUBLISHED: 2004, SOURCE: American Journal of Obstetrics and Gynecology, VOLUME: 190, ISSUE: 5
INDEXED IN: Scopus CrossRef: 3
Page 24 of 32. Total results: 317.